WHO ICTRP trial
Hemadsorption through supportive establishment of an Oxiris® filter in septic…
DRKS00027287 · German Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | DRKS00027287 |
|---|---|
| Public title | Hemadsorption through supportive establishment of an Oxiris® filter in septic shock with suspected cytokine release syndrome - a randomized controlled intervention study |
| Scientific title | Hemadsorption through supportive establishment of an Oxiris® filter in septic shock with suspected cytokine release syndrome - a randomized controlled intervention study - HEMOXISE- HEMoadsorption with OXIris in Septic shock with cytocinE storm- a randomized controlled trial |
| Primary sponsor | Klinik für Anästhesiologie Universitätsklinikum Heidelberg |
| Registry | German Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Germany |
| Conditions | R57.2;Septic shock;R57.2 |
| Interventions | Group 1: Hemoadsorption and filtration with the Oxiris® filter for 72 hours in the intervention group Group 2: Hemoadsorption and filtration with standard hemofilters in the control group |
| Registration date | Jan 24, 2022 |
| Target size | 100 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: